ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,642, issued on April 14, was assigned to SIGNUM BIOSCIENCES INC (Monmouth Junction, N.J.). "Compositions derived from Salvia hispanica see... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,644, issued on April 14, was assigned to Academia Sinica (Taipei, Taiwan). "Treatment of coronavirus infection with Flt3 receptor interact... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,646, issued on April 14, was assigned to CYTOVATION ASA (Bergen, Norway). "Peptide-containing composition for use for treating neoplastic ... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,648, issued on April 14. "Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain ... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,650, issued on April 14, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Inhibition of SIRP-gamma for cancer treatment" was invented ... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,652, issued on April 14, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "Serum albumin-binding fibronectin type III domains" was inv... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,654, issued on April 14, was assigned to BEIJING KIMWAY BIOTECH Co. LTD (Beijing). "Immunogenic peptide fragments of metalloprotease ADAMT... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,656, issued on April 14. "Methods for treating HPV-associated diseases" was invented by Scott Loughhead (Durham, N.C.), LeeAnn Talarico (M... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,658, issued on April 14, was assigned to Oregon Health & Science University (Portland, Ore.). "Hepatitis B virus-specific T cell responses... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,664, issued on April 14, was assigned to Novartis AG (Basel, Switzerland). "Pharmaceutical products and stable liquid compositions of IL-1... Read More